Biopharmaceutical revenue share in Germany 2018 by application field

This statistic shows the share of pharmaceutical revenues in Germany as of 2018, by field of application. That year, 40 percent of the revenues came from oncological pharmaceuticals.

Share of biopharmaceutical revenues in Germany as of 2018, by field of application

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

June 2019



Survey time period


Supplementary notes

Calculated on the total net revenue (pharmacy and hospital market in statutory and private insurance segments) after ApU (selling price pharmaceutical companies) minus the statutory manufacturer deductions
* Among other TNF-α inhibitors. excluding multiple sclerosis (see CNS)
** Exclusive hematological oncology.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.